Depo-Provera

Total Page:16

File Type:pdf, Size:1020Kb

Depo-Provera Treatment of Sex Offenders with Depo-Provera Theodore A. Kiersch, MD Medroxyprogesterone acetate (MPA) is capable of reducing male testosterone blood levels with a corresponding reduction in sexual interest and activity. An attempt to evaluate its effectiveness with court committed sexual offenders was made with eight subjects each serving as his own control by alternating Depo- Provera injections for 16 weeks with saline injections for a corresponding 16 weeks. This paper reports the results of this study and the conclusions that appear to be appropriate. California abolished its Mentally Dis- upon the central nervous system. In ordered Sexual Offender Laws January spite of the unknowns the question 1, 1982. On that date, there were over raised was could its effectiveness be re- 500 MDSOs in Atascadero State Hos- liably assessed in a maximum security pital. By 1984, there still remained over hospital with court committed sexual 270 hard-core offenders. Hard-core of- offenders. fenders were repeat offenders or patients Atascadero State Hospital was actively who had not achieved a recommenda- using a variety of treatment modalities tion for outpatient treatment after more including individual and group therapy, than two-and-a-half years in the hospi- sex education, behavior modification, tal. psychodrama, Alcoholics Anonymous, Depo-Provera (medroxyprogesterone Social Skills Group, education, and oc- acetate [MPC]) had been used since cupational and recreational therapy. All 1968 to modify sexual behavior by a these efforts were directed at helping the variety of investigators, generally with patient to make a better adult social favorable results.'-' The source of Depo- adjustment and eliminate sexual deviant Provera's biological effect is not exactly behavior. known. It is believed that sexual arous- The hospital also had a fully equipped ability is facilitated by testosterone, and sexual behavior laboratory capable of it is known that Depo-Provera dimin- measuring male sexual responses to a ishes testosterone production. However, variety of visual-auditory stimuli and it is also known that Depo-Provera has self-generated audio cassettes of fanta- a sedating, even an anesthetic, effect sies. The laboratory was equipped with mercury filled strain gauges capable of Presented at the 1988 annual meeting of the American accurately measuring penile responses to Academy of Psychiatry and the Law in San Francisco, California. ~timuli.~ Kiersch In order to attempt to answer the lower than 250 ng/100 ml as suggested question of the effectiveness of Depo- by Gagne.5 Provera in this setting, eight volunteers Each patient served as his own con- were chosen for a research project. Four trol, and for 16 weeks was given MPA subjects completed the proposed 64- in dosages of 100 to 400 mg per week or week study, and the remaining four injections of sterile saline in comparable completed 22 to 34 weeks of the study. liquid volume. The MPA and sterile sa- The volunteers were less than 40 years line were to be alternated in each patient of age, in good physical health, and free for four blocks of 16 weeks covering a of serious mental disorders such as psy- total of 64 weeks. chosis, mental retardation, affective dis- Each patient self-reported daily such order, or organic brain syndrome. They things as frequency of fantasies and mas- had to be capable of giving informed turbation in response to deviant and consent after all of the possible hazards nondeviant fantasies. He also reported were thoroughly explained. on possible side effects of the medica- The effectiveness of Depo-Provera tion. was evaluated by patients' self-reports Each patient was evaluated weekly in and sexual behavior laboratory measure- the sexual behavior laboratory to mea- ments. All the patients were continued sure his arousal to deviant and nondev- with their regular treatment programs, iant stimuli. The assumption existed and the Depo-Provera evaluations were that when the subject was receiving an added feature. MPA and his testosterone level fell to The patients were given injections below 250 ng/100 ml, his rate of mas- weekly of a substance identified only as turbation to both deviant and nondev- research material and told that MPA iant fantasies would decrease. It was also (Depo-Provera) was being given in vari- assumed that sex lab evaluations would able doses from zero to 400 mg per week. show a decline significantly to both de- The syringes were prepared by the hos- viant and nondeviant stimuli. Further- pital pharmacist and the material in- more, it was assumed that when the jected by a nurse in the medical/surgical patient was in the 16-week segment of clinic, which was entirely separate from saline injections his responses would be the patient's home ward. similar to his pretreatment evaluations. The treatment staff was unaware of Figure 1 represents the anticipated the dosage and quality of the research serum testosterone level responses to material, as was the sexual behavior lab- MPA or saline. oratory and the patient. Blood testoster- When serum testosterone levels were one levels were determined every two low, it was anticipated that rates of mas- weeks and the dosage of MPA or saline turbation to deviant and nondeviant adjusted dependent upon the blood tes- fantasies, if reliably reported, would also tosterone level. The goal was to maintain be low and high when the testosterone the subject's plasma testosterone level levels were high. 180 Bull Am Acad Psychiatry Law, Vol. 18, No. 2, 1990 Treatment of Sex Offenders with Depo-Provera Figure 1. Anticipated serum testosterone level responses to MPA or saline. Finally, it was anticipated that meas- cent are not considered significant. The ured penile erection responses would be reported masturbation frequencies and significantly modified if the subject was sex lab results were unchanged through- on the MPA 16-week cycle. out the 64 weeks regardless of saline or MPA injections. The interpretation of Subject 1 these results is either an excellent ex- A 25-year-old rapist on the MPA-sa- ample of behavior modification based line-MPA-saline sequence self-reported on suggestion or inaccurate reporting by the seventh week no deviant fantasies and noncompliant behavior in the sex- and no masturbation to either deviant ual behavior laboratory, probably the or nondeviant fantasies. By the sixth latter. week, his sex lab results were insignifi- cant arousal to deviant rape and 75 to Subject 2 100 percent arousal to nondeviant (con- A 38-year-old pedophile on the saline- senting adult) stimuli (Fig. 2). Sex labo- MPA-saline-MPA sequence was appar- ratory arousal rates of less than 20 per- ently cooperative. His reported deviant Figure 2. Subject 1. Bull Am Acad Psychiatry Law, Vol. 18, No. 2, 1990 Kiersch sexual fantasies were significantly re- report a decrease in deviant fantasies duced by saline and increased by MPA. that coincided with a decrease in mas- This paradoxical result is either the re- turbation to deviant stimuli during the sult of suggestion, inaccurate reporting, first 16-week MPA period. However, his or an attempt to overcome the effect of reported masturbatory activity re- MPA by use of previously learned effec- mained constant after the first 16 weeks. tive fantasies. The remainder of the stud- His penile response to deviant sexual ies, however, suggest inaccurate report- ing. His rate of masturbation was not stimuli was reduced during the first 16 influenced by MPA. His penile re- week period coinciding with his decrease sponses to child deviant stimuli was too in deviant fantasies. The next 48 weeks, variable to be certain as to the effect of however, were quite erratic and equivo- saline versus MPA. His penile responses cal from which conclusions could not be to nondeviant stimuli (adult) were un- reached (Fig. 4). affected by either saline or MPA and generally low. It should be noted how- Subject 4 ever, that once his testosterone level was A 30-year-old pedophile on the MPA- lowered by Depo-Provera during weeks saline-MPA-saline sequence reported a 16 to 32, it increased moderately during decrease in deviant fantasies and a de- the saline phase weeks 32-48 and did crease in deviant stimuli masturbation not rise above the recommended 250 during the first 16-week MPA sequence. ng/100 ml level (Fig. 3). His sex lab measurements revealed a Subject 3 corresponding decrease in deviant sex- A 28-year-old pedophile on the MPA- ual arousal during the same 16 weeks. saline-MPA-saline sequence indeed did Thereafter, he accepted the injections Figure 3. Subject 2. 182 Bull Am Acad Psychiatry Law, Vol. 18, No. 2, 1990 Treatment of Sex Offenders with Depo-Provera Figure 4. Subject 3. and serum testosterone studies but re- Subject 6 fused to cooperate with penile measure- A 33-year-old pedophile was on the ments or engage in self-reporting. Of saline-MPA-saline-MPA sequence. His interest was the fact that his testosterone deviant fantasies, rate of masturbation, levels did correspond with anticipated and nondeviant penile arousal were all levels. There was a prompt decrease in significantly lowered during the saline serum testosterone levels with the MPA injections. After his fifth MPA injection, injections and a six to eight week delay he complained that his testicles were in return to normal during the saline shrinking and withdrew from the re- injections (Fig. 5). search project. Physical examination re- Subject 5 vealed no change in the size of his testi- A 2 1 -year-old rapist and attempted cles. It only can be assumed that he murderer on the saline-MPA sequence. noted a reduction in his sexual desires He was returned to court on a writ to or had difficulty obtaining an erection complete his sentence in prison after 32 (Fig.
Recommended publications
  • Physiology of Female Sexual Function and Dysfunction
    International Journal of Impotence Research (2005) 17, S44–S51 & 2005 Nature Publishing Group All rights reserved 0955-9930/05 $30.00 www.nature.com/ijir Physiology of female sexual function and dysfunction JR Berman1* 1Director Female Urology and Female Sexual Medicine, Rodeo Drive Women’s Health Center, Beverly Hills, California, USA Female sexual dysfunction is age-related, progressive, and highly prevalent, affecting 30–50% of American women. While there are emotional and relational elements to female sexual function and response, female sexual dysfunction can occur secondary to medical problems and have an organic basis. This paper addresses anatomy and physiology of normal female sexual function as well as the pathophysiology of female sexual dysfunction. Although the female sexual response is inherently difficult to evaluate in the clinical setting, a variety of instruments have been developed for assessing subjective measures of sexual arousal and function. Objective measurements used in conjunction with the subjective assessment help diagnose potential physiologic/organic abnormal- ities. Therapeutic options for the treatment of female sexual dysfunction, including hormonal, and pharmacological, are also addressed. International Journal of Impotence Research (2005) 17, S44–S51. doi:10.1038/sj.ijir.3901428 Keywords: female sexual dysfunction; anatomy; physiology; pathophysiology; evaluation; treatment Incidence of female sexual dysfunction updated the definitions and classifications based upon current research and clinical practice.
    [Show full text]
  • Arousing Imaginations
    Evolutionary Psychology www.epjournal.net – 2007. 5(4): 778-785 ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ Book Review Arousing Imaginations A review of Michael R. Kauth, (Ed.), Handbook of the Evolution of Human Sexuality, Haworth Press, Binghamton, NY, 2006, 395 pp., $50.00 (softbound), $130.00 (hardbound) Reviewed by David Puts, Ph.D. Department of Anthropology, 424 Carpenter Building, Pennsylvania State University, University Park, PA 16802. Email: [email protected] In the quarter century since Donald Symons (1979) wrote The Evolution of Human Sexuality, research in this area has flourished. Michael Kauth’s edited volume Handbook of the Evolution of Human Sexuality (co-published as Volume 18, Numbers 2/3 and 4 2006 of the Journal of Psychology & Human Sexuality) is therefore a welcome addition. Kauth assembles researchers in diverse areas of human sexuality, including heterosexual mate choice, sexual arousal and olfactory preferences, but the focus is heavily upon the evolution and development of homosexuality, with five of the book’s ten chapters centering on this topic. Given that only 2-3% of men and 1-2% of women report predominantly homosexual preferences, this focus may seem disproportionate. However, the volume is intended not to cover all aspects of human sexuality but to serve as a springboard for future research, a mission that it will undoubtedly accomplish. The scholarship in the Handbook is variable but generally good. The content is often heavy on speculation and light on evidence, which would be less concerning if authors acknowledged this more openly. Instead, the chapters of the Handbook often reify “facts” that are still quite theoretical—for example, Kauth’s statement that “physical symmetry and extravagant sexual ornamentation are ‘honest’ signals of health and genetic quality” (p.
    [Show full text]
  • Drug-Induced Sexual Dysfunction in Men and Women
    VOLUME 36 : NUMBER 2 : APRIL 2013 ARTICLE Drug-induced sexual dysfunction in men and women Helen M Conaglen whether the clinician is willing to ask about sexual Clinical psychologist and SUMMARY issues and does so in a sensitive way.7,8 Senior research fellow Many medical conditions and their treatments Patients on long-term medications may not be John V Conaglen aware that their sexual problems have developed Endocrinologist and contribute to sexual dysfunction. as a result of their treatment. Conversely some may Associate professor in Commonly implicated drugs include Medicine blame their drugs for sexual problems which are due Sexual Health Research Unit antihypertensives, antidepressants, to relationship difficulties or other stressors. Some Waikato Clinical School antipsychotics and antiandrogens. doctors consider that asking patients if they had Faculty of Medical and Understanding the potential for drug-induced noticed any sexual adverse effects from their drugs Health Sciences University of Auckland sexual problems and their negative impact may ‘suggest’ them to the patient, and possibly result on adherence to treatment will enable the in non-adherence. Patients attributing their sexual clinician to tailor treatments for the patient problems to their drugs are less likely to continue the Key words treatment even when necessary for their health.9 The antidepressants, and his or her partner. consultation should include discussion of the patient’s antihypertensives, Encouraging a discussion with the patient sexual issues so these can be considered in treatment antipsychotics, arousal, about sexual function and providing erectile dysfunction, decisions. hypoactive sexual desire strategies to manage the problem are critical disorder, male impotence, to good clinical care.
    [Show full text]
  • The Effect of Contraceptive Implants on Sexual Desire in Women Zoë Tessier and Katrina Armstrong | Faculty of Health Science | University of Ottawa
    Are contraceptives causing the bedroom blues? The effect of contraceptive implants on sexual desire in women Zoë Tessier and Katrina Armstrong | Faculty of Health Science | University of Ottawa ABSTRACT METHODS DISCUSSION Background: In the United States, an estimated 51% of pregnancies are unwanted (Sanders et. al., 2014). High rates of unwanted • The main finding of the structured literature review was a decrease in sexual desire in women using contraceptive implants. pregnancy can be reduced by the use of various contraceptives. Hormonal contraceptives are a popular choice among fertile women PubMed, Medline, and Scopus were searched for relevant However the studies did not provide satisfactory evidence to draw a confident conclusion. and have been shown to effectively prevent pregnancy. Contraceptive implants are a type of progestogen-only birth control. The articles. “Contraceptive implants” and “libido” were initially • The Di Carlo and Sanders articles used the “Female Sexual Function Index” (FSFI) and the “Short Form-36” (SF-36) as a tool to implant is a single rod that is inserted subdermally into the upper arm. It has 68 mg of active compound and is effective in searched under the PubMed database. “Contraception” and measure sexual desire. All other articles failed to explicitly indicate the controls and measures used to determine libido. preventing pregnancy for up to 3 years (Gezginc et. al., 2007). Objective: Examine if contraceptive implants decrease a woman’s “drug implants” combined with “sexual dysfunction” or “libido” • Two articles described an increase in sexual desire while the remaining four reported a decrease. The increases were believed to sexual desire via a literature review.
    [Show full text]
  • Post-Orgasmic Illness Syndrome: a Closer Look
    Indonesian Andrology and Biomedical Journal Vol. 1 No. 2 December 2020 Post-orgasmic Illness Syndrome: A Closer Look William1,2, Cennikon Pakpahan2,3, Raditya Ibrahim2 1 Department of Medical Biology, Faculty of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia 2 Andrology Specialist Program, Department of Medical Biology, Faculty of Medicine, Universitas Airlangga – Dr. Soetomo Hospital, Surabaya, Indonesia 3 Ferina Hospital – Center for Reproductive Medicine, Surabaya, Indonesia Received date: Sep 19, 2020; Revised date: Oct 6, 2020; Accepted date: Oct 7, 2020 ABSTRACT Background: Post-orgasmic illness syndrome (POIS) is a rare condition in which someone experiences flu- like symptoms, such as feverish, myalgia, fatigue, irritabilty and/or allergic manifestation after having an orgasm. POIS can occur either after intercourse or masturbation, starting seconds to hours after having an orgasm, and can be lasted to 2 - 7 days. The prevalence and incidence of POIS itself are not certainly known. Reviews: Waldinger and colleagues were the first to report cases of POIS and later in establishing the diagnosis, they proposed 5 preliminary diagnostic criteria, also known as Waldinger's Preliminary Diagnostic Criteria (WPDC). Symptoms can vary from somatic to psychological complaints. The mechanism underlying this disease are not clear. Immune modulated mechanism is one of the hypothesis that is widely believed to be the cause of this syndrome apart from opioid withdrawal and disordered cytokine or neuroendocrine responses. POIS treatment is also not standardized. Treatments includeintra lymphatic hyposensitization of autologous semen, non-steroid anti-inflamation drugs (NSAIDs), steroids such as Prednisone, antihistamines, benzodiazepines, hormones (hCG and Testosterone), alpha-blockers, and other adjuvant medications.
    [Show full text]
  • Sexual Dysfunction in Men and in Women
    888-387-7218 @PharmXhealthOne @PharmXhealthOne Schedule your appointment today with a friendly sta member or book online today: LOW-INTENSITY EXTRACORPOREAL Toll-free 888-387-7218 SHOCK WAVE THERAPY Phone 561-847-4654 Fax 561-847-4956 Both men and women go through the same phases of sexual reactions cycle: sexual desire, sexual arousal, and, as a result, orgasm and reso- Email health@pharmxheal- lution phase. During the phase of sexual arousal, in both men and women, the blood flow to pelvic organs increases, but in the event of erectile dysfunction in men and frigidity in women, this process weak- ens or does not occur at all. Furthermore, the innervation of genital organs in male and female organisms is identical. Activation, which enables genital innervation, launches the activation of blood circula- PharmXhealthOne wellness center has tion in the target organs. three convenient locations: Therefore, in case of ED in men, and in case of female sexual arousal disorder in women, along with other specific treatment methods, it is 1054 Gateway Blvd, Suite 103 useful to perform non-invasive stimulation of insuciently active physiological mechanisms of sexual arousal. However, for the treat- Boynton Beach, FL 33426 ment of ED in men, such stimulation has already been successfully (561) 847-4654 used for a long time – that is the low-intensity extracorporeal shock (561) 847-4956 fax wave therapy, which allows to restore the erection mechanism itself. [email protected] SEXUAL Studies from throughout the world, including those conducted by Ukrainian scientists, have established that low-intensity extracorpore- al shock wave therapy induces neovascularization and therefore 808 SW Glenview Ct, Suite 818 improves blood circulation.
    [Show full text]
  • Sexuality and Chronic Pain
    Sexuality and Chronic Pain By Judith Paice, PhD, RN, Research Professor of Medicine, Northwestern University Medical School, Chicago, IL Re-printed with permission from the American Chronic Pain Association Chronicle. Sexuality is a significant part of who we are as individuals, providing intimacy, affection, social interaction, and touch. We are sexual beings from the moment of birth to the end of our lives. Sexual practices and beliefs wary widely, often based upon age, gender, past experiences, as well as religious and cultural values. As a result, each person and partner defines what is considered “normal” sexual behavior. There are four phases involved in the sexual response: desire, excitement, orgasm, and resolution. Desire is interest in sex, also called libido. Excitement is a state of arousal that often occurs as a result of touching and kissing. During excitement the body responds by increasing the heart rate, blood pressure, and respiratory rate. Blood flow will increase to the genitals in both men and women. In men, this results in an erection. The third phase, orgasm, is also called climax. Muscles in the genitalia contract, resulting in waves of pleasure throughout the body. Finally, resolution is the return of the body to its original state. Unfortunately, chronic pain and its treatment can impair our ability to express sexuality by altering any of the four phases. Few studies have evaluated the frequency of changes in sexual desire or function in people with chronic pain. One study of patients enrolled in chronic pain treatment programs in England found that 73 percent had some degree of sexual problems (Ambler et al.
    [Show full text]
  • Sexual and Life Satisfaction of Pregnant Women
    International Journal of Environmental Research and Public Health Article Sexual and Life Satisfaction of Pregnant Women Dorota Branecka-Wo´zniak 1,*, Anna Wójcik 2, Joanna Bła˙zejewska-Ja´skowiak 1 and Rafał Kurzawa 1 1 Department of Gynecology and Reproductive Health, Pomeranian Medical University of Szczecin, 71-210 Szczecin, Poland; [email protected] (J.B.-J.); [email protected] (R.K.) 2 Clinic of Obstetrics and Gynecology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University of Szczecin, 71-252 Szczecin, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-91-480-0920 Received: 30 June 2020; Accepted: 11 August 2020; Published: 13 August 2020 Abstract: The awareness of one’s own sexuality and its expression depend on the stage of an individual’s life. Pregnancy is a period of many, also psychosexual, changes. The sexual needs of pregnant women are rarely discussed, and intercourse during this period seems to be a taboo. The aim of this study was to assess the sexual and life satisfaction of pregnant women. The study involved 181 pregnant women and was conducted from July to November 2018. The participants were patients of the pregnancy pathology ward, Independent Public Clinical Hospital No. 2 in Szczecin, and participants of antenatal classes. The research project was approved by the Bioethics Committee of the Pomeranian Medical University, Szczecin (KB-0012/74/18). This survey-based study was performed using the self-developed questionnaire and standardized tools: the Sexual Satisfaction Questionnaire, and the Satisfaction with Life Scale (SWLS). Statistical analysis was performed using the SPSS Statistics 24.0 statistical package.
    [Show full text]
  • Sexuality Development and Developmental Psychology
    Chapter 6 Sexuality Development and Developmental Psychology While most humans appear to invoke free will regarding their sexual behav- ior, their sexuality in turn often seems to subvert a great deal of this will. That is, our sexual desires, inclinations, and identity greatly influence our decisions and behavior. People tacitly accept this principle when they advocate imprisonment for individuals who commit sex crimes against children. Implicit in this involuntary commitment process is the premise that the offender will not be able to control himself or herself against committing future offenses and thus should be physically prevented from doing so. This generally accepted act of prevention applies to the most extreme and dangerous sexual behaviors. But is the violent pedophile really less in control of his sexual behavior than those individuals who exhibit socially acceptable forms of sexuality? Or, is it that most of the population enacts a sexual- ity that is no more under control but considered a normative part of both nature and society? In essence, the issue is—regardless of the sexual behavior that an individual engages in—whether he or she is ultimately in control of that behavior. Wine connoisseurs often encourage the uninitiated to educate their palates to better appreciate fine wines. In doing so, they are encouraging people to suppress their innate aversion to what is essentially rancid grape juice with a bit of alcohol. With repeated exposure to the initially repellant properties of the wine, and with the guidance of an expert identifying specific hedonic properties, an individual can come to identify what is deemed to be a desirable wine.
    [Show full text]
  • S100005 Sex and Birth Control
    Sex and Birth Control: Are they connected? About 25% of women will have decreased sexual thoughts and arousability on Hormonal Contraception Enjoying sex is related to motivation for birth control The type of hormone, IUD or barrier may affect sexual pleasure There are biological drives to reproduce at odds with logical life plans REFERENCES 1. Schaffir J. Hormonal contraception and sexual desire: A critical review. J Sex Marital Ther. 2006;32:305-14 2. Oinonen, K. A. and D. Mazmanian. To what extent do oral contraceptives influence mood and affect? J Affect Disord. 2002;70(3):229-240. 3. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64(1):51-58. 4. Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006 Sep;74:220-3. 5. Wiebe ER, Brotto L, MacKay J. Characteristics of women who complain of mood and sexual side effects from hormonal contraception J Obstet Gynaecol Can 2011;33(11):1234-40. 6. Oinonen KA. Putting a finger on potential predictors of oral contraceptive side effects: 2D:4D and middle-phalangeal hair. Psychoneuroendocrinology. 2009 Jun;34(5):713-26. 7. Wallwiener M, Wallwiener L, Seeger H, Mueck AO, Bitzer J, Wallwiener CW. Effects of sex hormones in oral contraceptives on the female sexual function score: A study in German female medical students. Contraception; Volume 82, Issue 2, August 2010, Pages 155-159 8. Wiebe ER, Kaczorowski J, MacKay J.
    [Show full text]
  • Disorders of Ejaculation: an AUA/SMSNA Guideline - American Urological Association
    02.07.2020 Disorders of Ejaculation: An AUA/SMSNA Guideline - American Urological Association Home Guidelines Clinical Guidelines Disorders of Ejaculation Disorders of Ejaculation: An AUA/SMSNA Guideline Panel Members Alan W. Shindel MD, Stanley E. Althof, Ph.D., Serge Carrier, MD, Roger Chou, MD, FACP, Chris G. McMahon, MD, John P. Mulhall, MD, Darius A. Paduch, MD, Ph.D., Alexander W. Pastuszak, MD, Ph.D., David Rowland, Ph.D., Ashely H. Tapscott, MD , Ira D. Sharlip MD. Executive Summary Ejaculation and orgasm are distinct but simultaneous events that occur with peak sexual arousal. It is typical for men to have some control over the timing of ejaculation during a sexual encounter. Men who ejaculate before or shortly after penetration, without a sense of control, and who experience distress related to this condition may be diagnosed with Premature Ejaculation (PE). There also exists a population of men who experience difficulty achieving sexual climax, sometimes to the point that they are unable to climax during sexual activity; these men may be diagnosed with Delayed Ejaculation (DE). While up to 30% of men have self- reported PE, few of these men have an ejaculation latency times (the time between penetration and ejaculation) of less than two minutes, making the actual prevalence of clinical PE and DE less than 5%.1, 2 Regardless, the experience of many clinicians suggest that the problem is not rare and can be a source of considerable embarrassment and dissatisfaction for patients. Data on the prevalence of DE are more limited, but a proportion of epidemiological studies report that men have difficulty achieving orgasm.3 Disturbances of the timing of ejaculation can pose a substantial impediment to sexual enjoyment for men and their partners.
    [Show full text]
  • Understanding Low Libido in Women
    Understanding Low Libido in Women Contents What is Low Libido? 3 How is Libido Classified? 3 Why Does Low Libido Develop? 5 Who Develops Low Libido? 9 When Should I Be Concerned? 9 What are the Signs and Symptoms of Low Libido? 10 What is Normal Sexual Activity? 11 Testosterone and Women 12 Using Testosterone in Women – Options? 14 Seeking Medical Assistance 16 Female Sexual Function Questionnaire 17 Sexual History 23 Physical Examination 24 Sexual Response Review 26 Switching Contraceptive Method 29 Diagnostics 30 Psychological Assessment 34 Specialist Referral Options 35 Additional Treatment Options 36 What About Homeopathic and Herbal Treatments? 37 About Lawley Pharmaceuticals 38 Our Mission Statement 38 Completed Clinical Studies 39 Copyright Information 40 2 What is Low Libido? Libido is the sex drive. It is the necessary forerunner of sexual fantasy, arousal and sexual enjoyment. Low libido is a serious condition because it can diminish psychological health and well-being, and impacts on personal relationships. Low libido can be extremely well managed with appropriate treatment. Often women are too shy or feel uncomfortable discussing issues relating to sexual function, including low libido, and they may experience unfulfilling sexual and personal relationships as a result. How is Libido Classified? Every woman can experience short-term, intermittent disinterest in sex due to fatigue, acute illness, or stress. True low libido is a persistent, enduring disorder causing personal distress. There are four distinct medical classifications of female sexual dysfunction that result in low libido: Hypoactive Sexual Desire Disorder (HSDD) - The woman lacks sexual fantasies, has little or no sexual thoughts or inclination towards sexual activity of any kind or she is unreceptive to sexual activity.
    [Show full text]